RCA
LRCX icon

Riverview Capital Advisers’s Lam Research LRCX Stock Holding History

Riverview Capital Advisers’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
+598
New +$182K 0.07% 76

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Riverview Capital Advisers's LRCX Position: Q2 2026 in Review

Riverview Capital Advisers opened a new position in Lam Research (LRCX) in Q2 2026: 598 shares worth $259K. The stake represents 0.07% of the portfolio and ranks #76 among its holdings.

3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Riverview Capital Advisers held 598 shares of Lam Research worth $259K as of Q2 2026.
  • Lam Research was a new Riverview Capital Advisers position in Q2 2026.
  • Lam Research made up 0.07% of Riverview Capital Advisers's portfolio in Q2 2026, its #76 holding.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Riverview Capital Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.